Search Results - "Wong, Maida"
-
1
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus
Published in Proceedings of the National Academy of Sciences - PNAS (07-09-2010)“…Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disease that predominantly affects women. Previous findings that duplicated Toll-like receptor…”
Get full text
Journal Article -
2
Laquinimod Delays and Suppresses Nephritis in Lupus‐Prone Mice and Affects Both Myeloid and Lymphoid Immune Cells
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2014)“…Objective Lupus nephritis depends on autoantibody deposition and activation of multiple immune cell types that promote kidney inflammation, including…”
Get full text
Journal Article -
3
A Molecular Epidemiological Assessment of Extrapulmonary Tuberculosis in San Francisco
Published in Clinical infectious diseases (01-01-2004)“…The epidemiology of extrapulmonary tuberculosis (TB) is not well understood. We studied all cases of extrapulmonary TB reported in San Francisco during…”
Get full text
Journal Article -
4
Osteopontin Gene Polymorphism and Systemic Lupus Erythematosus in Chinese
Published in Clinical immunology (Orlando, Fla.) (01-01-2007)Get full text
Journal Article -
5
Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease
Published in The Journal of immunology (1950) (01-06-2013)“…Programmed death-1 (PD-1) usually acts as a negative signal for T cell activation, and its expression on CD8(+)Foxp3(+) T cells is required for their…”
Get full text
Journal Article -
6
CD8+ T Cell-Mediated Suppression of Autoimmunity in a Murine Lupus Model of Peptide-Induced Immune Tolerance Depends on Foxp3 Expression
Published in The Journal of immunology (1950) (15-06-2007)“…Systemic lupus erythematosus is an autoimmune disease caused by autoantibodies, including IgG anti-DNA. New Zealand Black/New Zealand White F(1) female mice, a…”
Get full text
Journal Article -
7
TNFα blockade in human diseases: Mechanisms and future directions
Published in Clinical immunology (Orlando, Fla.) (01-02-2008)“…Abstract Tumor necrosis factor-alpha (TNFα) antagonists have shown remarkable efficacy in a variety of immune-mediated inflammatory diseases (IMIDs)…”
Get full text
Journal Article -
8
TNFα blockade in human diseases: An overview of efficacy and safety
Published in Clinical immunology (Orlando, Fla.) (01-01-2008)“…Abstract Tumor necrosis factor-alpha (TNFα) antagonists including antibodies and soluble receptors have shown remarkable efficacy in various immune-mediated…”
Get full text
Journal Article -
9
Laquinimod suppression of lupus nephritis in BWF1 mice associates in renal tissue with increase of myeloid suppressor cells and switch of macrophages to anti-inflammatory type II (P5193)
Published in The Journal of immunology (1950) (01-05-2013)“…Abstract Background: Laquinimod (LAQ) is a novel drug that has been in clinical trial in systemic lupus erythematosus (SLE), an autoimmune disease…”
Get full text
Journal Article -
10
Blockade of Programmed death-1 induces functional CD4+ regulatory T cells to resist apoptosis in (New Zealand Black x New Zealand White)F1 lupus-prone mice (115.25)
Published in The Journal of immunology (1950) (01-04-2011)“…Abstract PD-1 is a negative regulatory signal in T cells. We hypothesize that regulation of PD-1 signaling is required for maintenance of functional regulatory…”
Get full text
Journal Article -
11
Cutaneous vasculitis in breast cancer treated with chemotherapy
Published in Clinical immunology (Orlando, Fla.) (01-10-2008)“…Abstract A patient from the University of California Los Angeles Medical Center who developed cutaneous vasculitis during the course of treatment for…”
Get full text
Journal Article -
12
Altered PD-1-PD-L1 Pathway in CD8+ T cells of (New Zealand Black x New Zealand White) BWF1 Mice with Anti-PD-1 antibody (99.29)
Published in The Journal of immunology (1950) (01-04-2009)“…Abstract PD1-PD-L1 is a costimulatory pathway that regulates self-tolerance by providing negative signals to T cells, resulting in anergy and decreased…”
Get full text
Journal Article -
13
Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosis
Published in Journal of rheumatology (01-01-2010)Get full text
Journal Article -
14
-
15
Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease
Published in The Journal of immunology (1950) (01-12-2010)“…The programmed death-1 (PD-1)/programmed death-1 ligand 1 (PD-L1) pathway regulates both stimulatory and inhibitory signals. In some conditions, PD-1/PD-L1…”
Get full text
Journal Article -
16
Current topics in human SLE genetics
Published in Springer seminars in immunopathology (01-10-2006)“…Susceptibility to systemic lupus erythematosus (SLE) depends on genetic and environmental factors. Genome scan studies have identified eight chromosomal…”
Get more information
Journal Article -
17
CD8 super(+) T Cell-Mediated Suppression of Autoimmunity in a Murine Lupus Model of Peptide-Induced Immune Tolerance Depends on Foxp3 Expression
Published in Journal of Immunology (01-06-2007)“…Systemic lupus erythematosus is an autoimmune disease caused by autoantibodies, including IgG anti-DNA. New Zealand Black/New Zealand White F sub(1) female…”
Get full text
Journal Article -
18
CD8+ T Cell- mediated Suppression of Autoimmunity in a Murine Lupus Model of Peptide-Induced Immune Tolerance Depends on Foxp3 Expression (130.19)
Published in The Journal of immunology (1950) (01-04-2007)“…Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease caused by autoantibodies including IgG anti-DNA. NZB/NZW Fl female (BWF1) mice, a model of…”
Get full text
Journal Article -
19
TNFalpha blockade in human diseases: mechanisms and future directions
Published in Clinical immunology (Orlando, Fla.) (01-02-2008)“…Tumor necrosis factor-alpha (TNFalpha) antagonists have shown remarkable efficacy in a variety of immune-mediated inflammatory diseases (IMIDs). Therapeutic…”
Get full text
Journal Article -
20
TNFalpha blockade in human diseases: an overview of efficacy and safety
Published in Clinical immunology (Orlando, Fla.) (01-01-2008)“…Tumor necrosis factor-alpha (TNFalpha) antagonists including antibodies and soluble receptors have shown remarkable efficacy in various immune-mediated…”
Get full text
Journal Article